3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 3
1
Status
Terminated
4
Unknown
2
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Interventional
4
Sponsor
Cancer Type
Gastrointestinal
4
Conditions
Stomach Neoplasms
4
Esophageal Neoplasms
2
Rectal Neoplasms
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Adenocarcinoma
1
Interventions
Capecitabine
27
pembrolizumab
19
Oxaliplatin
19
Fluorouracil
17
Cisplatin
17
Trastuzumab
14
Docetaxel
14
Leucovorin
11
Paclitaxel
8
Irinotecan
8
S 1 (combination)
7
Epirubicin
6
Cyclophosphamide
5
tegafur-gimeracil-oteracil
4
aldesleukin
4
Hyperthermic Intraperitoneal Chemotherapy
4
titanium silicide
3
spartalizumab
3
fludarabine phosphate
3
fludarabine
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Ramucirumab
3
Nivolumab
3
Indocyanine Green
3
Gemcitabine
3
Carboplatin
3
Albumin-Bound Paclitaxel
3
Ado-Trastuzumab Emtansine
3
vistusertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Terminated
×
Stomach Neoplasms
×
tegafur-gimeracil-oteracil
×
Clear all
NCT05161572
2025-06-18
NeoRacing
Fudan University
Phase 2
Terminated
6 enrolled
NCT01285557
2024-09-19
DIGEST
Taiho Oncology, Inc.
Phase 3
Terminated
361 enrolled
18 charts
NCT02191566
2022-12-08
SOHUG
Kangbuk Samsung Hospital
Phase 2
Terminated
8 enrolled
NCT02216149
2018-08-28
FluoHeart
Helsinki University Central Hospital
Phase 2
Terminated
20 enrolled